Construction and Validation of Capture Probe Panels in Multiplex Immunoassays

Why Multiplex Assays Require Capture Probe Panels

In protein biomarker research, detecting individual factors one by one with ELISA not only consumes large amounts of sample but also fails to reflect the relationships among multiple indicators. A capture probe panel immobilizes capture molecules targeting different analytes on carriers such as microspheres, chips, or microwells, enabling the simultaneous reading of multiple signals in a single experiment. Capture molecules can be antibodies, nucleic acid aptamers, or affinity proteins, and their specificity and affinity determine the overall performance of the panel.

Antibody Pairing and Cross-Reactivity Control

When constructing an immunoassay-type capture probe panel, each target typically requires a matched capture antibody and detection antibody. Antibody pair screening is a time-consuming but critical step, requiring evaluation of binding signals and background under different buffer systems. Cross-reactivity directly interferes with result interpretation, especially when targets share sequence homology or common subunits. Generally, spike-in experiments with individual analytes, mixed spike-in experiments, and negative control experiments are needed to assess whether an antibody pair recognizes only the target protein.

Capture molecule immobilization methods: covalent coupling, affinity immobilization, or physical adsorption can affect activity and stability.

Signal readout methods: chemiluminescence, fluorescence, or electrochemiluminescence have different effects on sensitivity and dynamic range.

Buffer system: salt ion concentration, pH, protein stabilizers, etc., need to be optimized in a unified manner.

Sample Matrix and Normalization Strategies

Matrix components in serum, plasma, cell culture supernatant, or tissue lysate may interfere with the binding of capture probes to targets. Sample dilution, blocking agent selection, and standard curve preparation all need to consider matrix matching. In multiplex panels, the abundance of each target varies greatly, often requiring different dilution factors or the use of bridging samples for normalization to ensure that each indicator falls within the detectable range.

For data processing, one should not rely solely on a single internal reference or a single-point standard, but should use multi-point standard curves combined with quality control samples to evaluate intra-assay and inter-assay variation. For low-abundance proteins, signal amplification may be considered, but it must be verified whether it increases nonspecific background.

Validation and Lot-to-Lot Stability

Before a capture probe panel is formally used for sample testing, its sensitivity, specificity, precision, dilution linearity, and sample stability need to be validated. Different lots of panels may have differences in immobilization efficiency, so it is recommended to include standards and quality controls for each lot. Long-term storage conditions also require data accumulation through accelerated stability or real-time stability studies.

Reasonable validation work can reduce systematic bias in multiplex data and improve comparability across different experimental batches.